Overview

Compare the Pharmacokinetics of TAH(80/10/12.5) Tablet in Comparison to the Co-administration of Telmisartan, Amlodipine and Hydrochlorothiazide in Healthy Male Volunteers

Status:
Completed

Trial end date:
2016-12-27

Target enrollment:

Participant gender:

Summary

randomized, open-label, single dose, replicate crossover clinical trial to compare the pharmacokinetics of TAH(80/10/12.5) tablet in comparison to the co-administration of telmisartan, amlodipine and hydrochlorothiazide in healthy male volunteers

Phase:

Phase 1

Details

Lead Sponsor:

IlDong Pharmaceutical Co Ltd

Treatments:

Amlodipine
Hydrochlorothiazide
Telmisartan
Telmisartan amlodipine combination